Follow The Filings

ARAY Accuray Inc.

Health Care, filed as ACCURAY INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • Max 0.1%
  • $433K

Who owns this now

Largest portfolio weights among holders, up to 0.1% (Nathan Fischel, Dafna Capital Management). Not free-float ownership.

  1. Nathan Fischel 0.08%

Who owns ARAY

Sorted by value, long equity only, as of 2026 Q2.

History
Nathan Fischel, Dafna Capital Management 0.08% Hold 1,680,508 $433K History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by ARAY's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ARAY insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Steven F Mayer Director
    Buy
    — 54,875 shares +3.7% to stake
    Traded Feb 20 Filed Feb 23
    ↗
  2. Steven F Mayer Director
    Buy
    — 195,125 shares +15% to stake
    Traded Feb 18–19 Filed Feb 20
    ↗
  3. Stephen R. La Neve CEO
    Buy
    — 20,000 shares New stake
    Traded Nov 19, 2025 Filed Nov 19, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 13 option exercises, 9 share withholdings for taxes, and 4 stock grants.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
DEF 14A Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 5.02,5.07,8.01,9.01 Filing Doc
DEFA14A Filing Doc
424B3 FORM 424B3 Filing Doc
SCHEDULE 13D/A — Filing Doc
10-K FORM 10-K Filing Doc
DEF 14A Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
8-K 3.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 1.01,3.02,5.02,8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 1.02,7.01 Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q FORM 10-Q Filing Doc
8-K 5.02,9.01 Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 1.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.02,9.01 Filing Doc
424B3 FORM 424B3 Filing Doc

Source: SEC EDGAR submissions, updated 12 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025 FY2026
Revenue $447.6M $446.55M $458.5M $401.95M
Gross profit $153.96M $142.92M $146.97M $111.45M
Gross margin * 34.4% 32.0% 32.1% 27.7%
Net income -$9.28M -$15.54M -$1.59M -$49.19M
Net margin * -2.1% -3.5% -0.3% -12.2%

Balance sheet

Metric FY2023 FY2024 FY2025 FY2026
Total current assets $338.03M $323.24M $317.46M $287.78M
Total non-current assets * $141.18M $145.39M $152.77M $155.9M
Total assets $479.21M $468.63M $470.24M $443.68M
Total current liabilities $198.64M $195.27M $192.58M $191.4M
Total non-current liabilities * $226.92M $228.28M $196.49M $210.57M
Total equity $53.66M $45.08M $81.17M $41.7M

Cash flow

Metric FY2023 FY2024 FY2025 FY2026
Cash from operations $15.54M -$11.9M $2.86M -$6.98M
Cash from investing -$12.68M -$3.6M -$8.52M -$12.28M
Cash from financing -$2.11M -$3.95M -$4.25M $6.98M
Net change in cash $1.05M -$20.81M -$8.26M -$13.37M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.